Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 8, Pages 1281
Publisher
MDPI AG
Online
2017-08-02
DOI
10.3390/molecules22081281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL).
- (2017) R. W. Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
- (2016) John Y. Li et al. CANCER CELL
- Linkers Having a Crucial Role in Antibody–Drug Conjugates
- (2016) Jun Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current Status: Site-Specific Antibody Drug Conjugates
- (2016) Dominik Schumacher et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates
- (2016) P. J. Burke et al. MOLECULAR CANCER THERAPEUTICS
- Erratum: Corrigendum: Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Expanding the Reach of Antibody–Drug Conjugates
- (2016) Ravi V. J. Chari ACS Medicinal Chemistry Letters
- Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
- (2016) Jianhong Yang et al. Nature Communications
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
- (2015) Jessica R. McCombs et al. AAPS Journal
- Versatile and Efficient Site-Specific Protein Functionalization by Tubulin Tyrosine Ligase
- (2015) Dominik Schumacher et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases
- (2015) Pradman K. Qasba BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
- (2015) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- The cryptophycins as potent payloads for antibody drug conjugates
- (2015) Vishal A. Verma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
- (2015) Penny Bryant et al. MOLECULAR PHARMACEUTICS
- Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability
- (2015) Satish K. Singh et al. PHARMACEUTICAL RESEARCH
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
- (2015) Antoine Maruani et al. Nature Communications
- Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
- (2014) Andrea E. Prota et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
- (2014) George Badescu et al. BIOCONJUGATE CHEMISTRY
- Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
- (2014) Penelope M. Drake et al. BIOCONJUGATE CHEMISTRY
- Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling
- (2014) R. Cohen et al. CANCER RESEARCH
- FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
- (2014) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Exploring the effects of linker composition on site-specifically modified antibody–drug conjugates
- (2014) Aaron E. Albers et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The tubulin code: Molecular components, readout mechanisms, and functions
- (2014) Carsten Janke JOURNAL OF CELL BIOLOGY
- Synthetic Reactions with Rare Taccalonolides Reveal the Value of C-22,23 Epoxidation for Microtubule Stabilizing Potency
- (2014) Jiangnan Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hemiasterlin analogues incorporating an aromatic, and heterocyclic type C-terminus: design, synthesis and biological evaluation
- (2014) Giordano Lesma et al. MOLECULAR DIVERSITY
- The Next Generation of Antibody Drug Conjugates
- (2014) Fiona Mack et al. SEMINARS IN ONCOLOGY
- Clinical Status of Anti-Cancer Agents Derived from Marine Sources
- (2013) Ram Singh et al. Anti-Cancer Agents in Medicinal Chemistry
- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
- (2013) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Taccalonolide Binding to Tubulin Imparts Microtubule Stability and Potent In Vivo Activity
- (2013) A. L. Risinger et al. CANCER RESEARCH
- Colchicine Semisynthetics: Chemotherapeutics for Cancer?
- (2013) G. Sivakumar CURRENT MEDICINAL CHEMISTRY
- Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
- (2013) Harish Rajak et al. CURRENT PHARMACEUTICAL DESIGN
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Structural basis of tubulin tyrosination by tubulin tyrosine ligase
- (2013) Andrea E. Prota et al. JOURNAL OF CELL BIOLOGY
- Conjugates of Modified Cryptophycins and RGD-Peptides Enter Target Cells by Endocytosis
- (2013) Markus Nahrwold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
- (2013) Michael Ritchie et al. mAbs
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Recent approaches for the synthesis of modified cryptophycins
- (2013) Christine Weiss et al. NATURAL PRODUCT REPORTS
- Synthesis and structure–activity relationship studies of novel tubulysin U analogues – effect on cytotoxicity of structural variations in the tubuvaline fragment
- (2013) Sreejith P. Shankar et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Total synthesis and biological evaluation of fluorinated cryptophycins
- (2012) Christine Weiß et al. Beilstein Journal of Organic Chemistry
- Novel Drugs Targeting Microtubules: the Role of Epothilones
- (2012) Gabriella Ferrandina et al. CURRENT PHARMACEUTICAL DESIGN
- The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
- (2012) H. K. Erickson et al. MOLECULAR CANCER THERAPEUTICS
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
- (2011) Xiuxia Sun et al. BIOCONJUGATE CHEMISTRY
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- Developments of Combretastatin A-4 Derivatives as Anticancer Agents
- (2011) Y. Shan Shan et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
- (2011) Robert Y. Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent Taccalonolides, AF and AJ, Inform Significant Structure–Activity Relationships and Tubulin as the Binding Site of These Microtubule Stabilizers
- (2011) Jing Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Polymeric Dibromomaleimides As Extremely Efficient Disulfide Bridging Bioconjugation and Pegylation Agents
- (2011) Mathew W. Jones et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
- (2011) Franco Dosio et al. Toxins
- Site-Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
- (2010) Simone Jeger et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
- (2010) Y. V. Kovtun et al. CANCER RESEARCH
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Approaches for the Synthesis of Functionalized Cryptophycins
- (2010) Benedikt Sammet et al. JOURNAL OF ORGANIC CHEMISTRY
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Clicktophycin-52”: A Bioactive Cryptophycin-52 Triazole Analogue
- (2010) Markus Nahrwold et al. ORGANIC LETTERS
- Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates
- (2009) Hans K. Erickson et al. BIOCONJUGATE CHEMISTRY
- Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
- (2009) A. G. Polson et al. CANCER RESEARCH
- Antibody-Drug Conjugate Targets
- (2009) B. Teicher CURRENT CANCER DRUG TARGETS
- Recent advances of novel targeted therapy in non-small cell lung cancer
- (2009) Jed A Katzel et al. Journal of Hematology & Oncology
- Synthesis and Preliminary Biological Evaluation of High-Drug-Load Paclitaxel-Antibody Conjugates for Tumor-Targeted Chemotherapy
- (2009) Sherly Quiles et al. JOURNAL OF MEDICINAL CHEMISTRY
- A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
- (2009) M. M. Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate
- (2008) Svetlana O. Doronina et al. BIOCONJUGATE CHEMISTRY
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Polymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor Activity
- (2008) T. Schluep et al. CLINICAL CANCER RESEARCH
- Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
- (2008) Toshirou Nishida et al. International Journal of Clinical Oncology
- Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
- (2008) Robert K. Oldham et al. JOURNAL OF CLINICAL ONCOLOGY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- Tracking the ends: a dynamic protein network controls the fate of microtubule tips
- (2008) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
- Tamoxifen: Catalyst for the change to targeted therapy
- (2007) V. Craig Jordan EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started